List of Studies ( Metabolite:O-Acetyl-homoserine)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST001261 | AN002092 | Metabolic changes of culture supernatants of Fusobacterium nucleatum co-cultured with other oral microbes (part-II) | Bacterial cells | Fusobacterium nucleatum | Osaka University Graduate School of Dentistry | AU | |
ST003546 | AN005828 | Improved Soil Health and Pasture Phytochemical Richness Underlies Improved Beef Nutrient Density in Southern US Grass-Finished Beef Systems | Muscle | Cattle | Utah State University | AU | |
ST002155 | AN003530 | Longitudinal metabolomic stool dynamics in primary C. difficile infections | Feces | Human | Bacterial infection | Brigham Women's Hospital | intensity |
ST001788 | AN002899 | β-Adrenergic regulation of metabolism in macrophages (part-IV) | Macrophages | Human | Monash University | Intensity | |
ST001940 | AN003155 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003156 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003157 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003158 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST002498 | AN004657 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Blood | Human | Cancer | Weill Cornell Medicine | peak area |
ST001412 | AN002362 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Blood | Human | Obesity | University of Michigan | Peak area |
ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | Peak Area |
ST002066 | AN003365 | Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer | Lung | Mouse | Cancer | The Walter and Eliza Hall Institute of Medical Research | peak height |
ST002412 | AN003931 | Metabolic effects of the protein kinase R | Macrophages | Mouse | Hudson | peak height | |
ST002926 | AN004798 | Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression | Blood | Plasmodium falciparum | Malaria | Monash University | peak height |
ST003036 | AN004977 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Bacterial cells | Pseudomonas aeruginosa | Bacterial infection | Monash Institute of Pharmaceutical Sciences | peak height |
ST003521 | AN005782 | Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii | Bacterial cells | Acinetobacter baumannii | Bacterial infection | Monash University | peak height |
ST003521 | AN005783 | Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii | Bacterial cells | Acinetobacter baumannii | Bacterial infection | Monash University | peak height |
ST000403 | AN000643 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
ST000539 | AN000819 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
ST001033 | AN001694 | Determination of mode of action of anti-malalrial drugs using untargeted metabolomics | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak height |
ST001274 | AN002115 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | Peak height |
ST001276 | AN002117 | Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | Peak height |
ST001154 | AN001944 | A comprehensive plasma metabolomics dataset for a cohort of mouse knockouts within the International Mouse Phenotyping Consortium | Blood | Mouse | University of California | Peak height normalized with creatinine | |
ST001201 | AN001998 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001201 | AN001998 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001547 | AN002576 | β-Adrenergic regulation of metabolism in macrophages | Macrophages | Human | Monash University | Peak intensity | |
ST001547 | AN002577 | β-Adrenergic regulation of metabolism in macrophages | Macrophages | Human | Monash University | Peak intensity | |
ST001548 | AN002578 | β-Adrenergic regulation of metabolism in macrophages (part-II) | Macrophages | Human | Monash University | Peak intensity | |
ST001548 | AN002579 | β-Adrenergic regulation of metabolism in macrophages (part-II) | Macrophages | Human | Monash University | Peak intensity | |
ST001549 | AN002580 | β-Adrenergic regulation of metabolism in macrophages (part-III) | Macrophages | Human | Monash University | Peak intensity | |
ST001827 | AN002963 | The pregnancy metabolome from a multi-ethnic pregnancy cohort | Blood | Human | Icahn School of Medicine at Mount Sinai | pmoles/l | |
ST002819 | AN004592 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST002094 | AN003422 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST001178 | AN001954 | Metabolomic analysis of C2C12 myoblasts induced by the transcriptional factor FOXO1 | Muscle | Mouse | Kyoto Prefectural University | Relative Area | |
ST002309 | AN003771 | Targeting malaria parasites with novel derivatives of azithromycin | Blood | Plasmodium falciparum | Malaria | Monash University | relative intensity |
ST002729 | AN004423 | Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. | Muscle | Mouse | Diabetes | Medical Institute of Bioregulation, Kyushu University | relative peak area |
ST002017 | AN003287 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Blood | Human | Vanderbilt University Medical Center | scaled imputed | |
ST001175 | AN001950 | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | Signal Intensity |
ST001315 | AN002189 | Retargeting azithromycin-like compounds as antimalarials with dual modality | Blood | Plasmodium falciparum | Malaria | Monash University | Signal Intensity |